HAND2 and chronic myelogenous leukemia, BCR-ABL1 positive: In chronic myeloid leukemia (CML), down-regulation of HAND2-AS1 has been much prominent in accelerated and blast phases compared with chronic phase [18], indicating a putative prognostic role for this transcript.